122 related articles for article (PubMed ID: 10530949)
1. Oligosaccharides corresponding to the regular sequence of heparin: chemical synthesis and interaction with FGF-2.
Tabeur C; Mallet JM; Bono F; Herbert JM; Petitou M; Sinaÿ P
Bioorg Med Chem; 1999 Sep; 7(9):2003-12. PubMed ID: 10530949
[TBL] [Abstract][Full Text] [Related]
2. Properly oriented heparin-decasaccharide-induced dimers are the biologically active form of basic fibroblast growth factor.
Moy FJ; Safran M; Seddon AP; Kitchen D; Böhlen P; Aviezer D; Yayon A; Powers R
Biochemistry; 1997 Apr; 36(16):4782-91. PubMed ID: 9125499
[TBL] [Abstract][Full Text] [Related]
3. Solution structure of human acidic fibroblast growth factor and interaction with heparin-derived hexasaccharide.
Ogura K; Nagata K; Hatanaka H; Habuchi H; Kimata K; Tate S; Ravera MW; Jaye M; Schlessinger J; Inagaki F
J Biomol NMR; 1999 Jan; 13(1):11-24. PubMed ID: 10070748
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts.
Delehedde M; Lyon M; Gallagher JT; Rudland PS; Fernig DG
Biochem J; 2002 Aug; 366(Pt 1):235-44. PubMed ID: 12000311
[TBL] [Abstract][Full Text] [Related]
5. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides.
Ornitz DM; Herr AB; Nilsson M; Westman J; Svahn CM; Waksman G
Science; 1995 Apr; 268(5209):432-6. PubMed ID: 7536345
[TBL] [Abstract][Full Text] [Related]
6. Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.
Guglier S; Hricovíni M; Raman R; Polito L; Torri G; Casu B; Sasisekharan R; Guerrini M
Biochemistry; 2008 Dec; 47(52):13862-9. PubMed ID: 19117094
[TBL] [Abstract][Full Text] [Related]
7. Structural requirements in heparin for binding and activation of FGF-1 and FGF-4 are different from that for FGF-2.
Ishihara M
Glycobiology; 1994 Dec; 4(6):817-24. PubMed ID: 7537556
[TBL] [Abstract][Full Text] [Related]
8. Heparin structure and interactions with basic fibroblast growth factor.
Faham S; Hileman RE; Fromm JR; Linhardt RJ; Rees DC
Science; 1996 Feb; 271(5252):1116-20. PubMed ID: 8599088
[TBL] [Abstract][Full Text] [Related]
9. Conformational flexibility of a synthetic glycosylaminoglycan bound to a fibroblast growth factor. FGF-1 recognizes both the (1)C(4) and (2)S(O) conformations of a bioactive heparin-like hexasaccharide.
Canales A; Angulo J; Ojeda R; Bruix M; Fayos R; Lozano R; Giménez-Gallego G; Martín-Lomas M; Nieto PM; Jiménez-Barbero J
J Am Chem Soc; 2005 Apr; 127(16):5778-9. PubMed ID: 15839662
[TBL] [Abstract][Full Text] [Related]
10. Heparin-dependent fibroblast growth factor activities: effects of defined heparin oligosaccharides.
Zhou FY; Kan M; Owens RT; McKeehan WL; Thompson JA; Linhardt RJ; Höök M
Eur J Cell Biol; 1997 May; 73(1):71-80. PubMed ID: 9174673
[TBL] [Abstract][Full Text] [Related]
11. Solution NMR structure of a human FGF-1 monomer, activated by a hexasaccharide heparin-analogue.
Canales A; Lozano R; López-Méndez B; Angulo J; Ojeda R; Nieto PM; Martín-Lomas M; Giménez-Gallego G; Jiménez-Barbero J
FEBS J; 2006 Oct; 273(20):4716-27. PubMed ID: 16995857
[TBL] [Abstract][Full Text] [Related]
12. Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cells.
Jayson GC; Gallagher JT
Br J Cancer; 1997; 75(1):9-16. PubMed ID: 9000592
[TBL] [Abstract][Full Text] [Related]
13. A synthetic heparan sulfate pentasaccharide, exclusively containing L-iduronic acid, displays higher affinity for FGF-2 than its D-glucuronic acid-containing isomers.
Kovensky J; Duchaussoy P; Bono F; Salmivirta M; Sizun P; Herbert JM; Petitou M; Sinaÿ P
Bioorg Med Chem; 1999 Aug; 7(8):1567-80. PubMed ID: 10482449
[TBL] [Abstract][Full Text] [Related]
14. Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor.
Tyrrell DJ; Ishihara M; Rao N; Horne A; Kiefer MC; Stauber GB; Lam LH; Stack RJ
J Biol Chem; 1993 Mar; 268(7):4684-9. PubMed ID: 8444842
[TBL] [Abstract][Full Text] [Related]
15. Structure elucidation of a novel acidic tetrasaccharide and hexasaccharide derived from a chemically modified heparin.
Desai UR; Wang HM; Kelly TR; Linhardt RJ
Carbohydr Res; 1993 Mar; 241():249-59. PubMed ID: 8472255
[No Abstract] [Full Text] [Related]
16. Fluorous-tag assisted synthesis of a glycosaminoglycan mimetic tetrasaccharide as a high-affinity FGF-2 and midkine ligand.
Maza S; Gandia-Aguado N; de Paz JL; Nieto PM
Bioorg Med Chem; 2018 Mar; 26(5):1076-1085. PubMed ID: 29409708
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of vascular smooth muscle cell proliferation by a novel fibroblast growth factor receptor antagonist.
Segev A; Aviezer D; Safran M; Gross Z; Yayon A
Cardiovasc Res; 2002 Jan; 53(1):232-41. PubMed ID: 11744033
[TBL] [Abstract][Full Text] [Related]
18. Regulation of FGF-1 mitogenic activity by heparan sulfate oligosaccharides is dependent on specific structural features: differential requirements for the modulation of FGF-1 and FGF-2.
Pye DA; Vivès RR; Hyde P; Gallagher JT
Glycobiology; 2000 Nov; 10(11):1183-92. PubMed ID: 11087710
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic activity of acidic fibroblast growth factor is enhanced by highly sulfated oligosaccharides derived from heparin and heparan sulfate.
Gambarini AG; Miyamoto CA; Lima GA; Nader HB; Dietrich CP
Mol Cell Biochem; 1993 Jul; 124(2):121-9. PubMed ID: 7694075
[TBL] [Abstract][Full Text] [Related]
20. Oligomerization reduces heparin affinity but enhances receptor binding of fibroblast growth factor 2.
Safran M; Eisenstein M; Aviezer D; Yayon A
Biochem J; 2000 Jan; 345 Pt 1(Pt 1):107-13. PubMed ID: 10600645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
